SHS – The Company
For more than 20 years now, SHS has been investing in high-growth companies from the MedTech/Life Sciences sector in the German-speaking regions as well as Scandinavia and the Benelux countries. Our private equity investments are between € 2 to 20m per deal.
We consider ourselves as entrepreneurs and offer in-depth industry knowledge as well as networks along with capital. Hence, in order to guaranty substantial contribution, our investments are focused on a small number of businesses.
The focus of our current fund SHS IV is on private equity investments. Thus we are searching for small buyout situations as well as growth financings of later stage companies from the MedTech/Life Sciences sector. In addition the fund is also going to realize venture capital investments. That means that we are willing to invest in attractive, young, high-growth companies, too. Here you can find our investment focus at a glance.